Neuromodulation Devices Consumables and Associated Products 2013

Neuromodulation Devices Consumables and Associated Products 2013

We are interested in hearing from any Applicant who would like to be involved on a consultation process which is expected to take place early March 2013.

UK-Normanton: Electrodes

2013/S 030-046868

Prior information notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

NHS Supply Chain acting as agent for NHS Business Services Authority
NHS Supply Chain, Foxbridge Way
For the attention of: Jenny Moult
WF6 1TL Normanton
UNITED KINGDOM
Telephone: +44 7714041353
E-mail: jenny.moult@supplychain.nhs.uk

Internet address(es):

General address of the contracting authority: www.supplychain.nhs.uk

Further information can be obtained from: NHS Supply Chain acting as agent for NHS Business Services Authority
Internet address: http://procurement.supplychain.nhs.uk/

I.2)Type of the contracting authority

National or federal agency/office
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II.B: Object of the contract (Supplies or services)

II.1)Title attributed to the contract by the contracting authority:

Neuromodulation Devices Consumables and Associated Products 2013
II.2)Type of contract and place of delivery or of performance

Supplies
Various locations in UK.
NUTS code UK

II.3)Information on framework agreement
II.4)Short description of nature and quantity or value of supplies or services:

“Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of GBP 2 500 000 in the first year of this Framework Agreement however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
NHS Supply Chain is currently considering the use of Lots for this tender.
This framework agreement will be for but shall not be limited to; Devices Consumables and other products associated with Neuromodulation procedures such as:
– Spinal Cord Stimulation;
– Deep Brain Stimulation;
– Intrathecal Drug Pumps;
– Sacral Nerve Stimulation;
– Vagal Nerve Stimulation;
– Peripheral Nerve Stimulation;
– Occipital Nerve Stimulation;
– Hydrocephalus valves and shunts;
– Dorsal Root Ganglion Stimulation.
Please note that the list above are examples only and NHS Supply Chain may be interested in capturing other procedures or products that potential suppliers may consider relevant to the overarching requirement for Devices Consumables and other products that are associated with Neuromodulation procedures.
Estimated cost excluding VAT: 10 000 000 GBP
II.5)Common procurement vocabulary (CPV)

31711140, 33124100, 33124130, 33140000, 33141200, 33141210, 33141240, 33141310, 33141320, 33141323, 33141620, 33190000, 33698000, 38434540, 42122410, 33100000, 33158210, 33184100

II.6)Scheduled date for start of award procedures
II.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.8)Additional information:

The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
We are interested in hearing from any Applicant who would like to be involved on a consultation process which is expected to take place early March 2013.
The Framework Agreement between NHS Supply Chain and successful Applicants will reserve the right to purchase the same or similar supplies and/or services from Applicants not appointed to the Framework Agreement at its sole discretion.
Whilst it is anticipated that initial expenditure under any forthcoming procurement will be in the region of GBP 10 000 000 for this contract award this is approximate only and the values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.
NHS Supply Chain expects to provide successful suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing value added offerings and commitment/bulk buy initiatives.
NHS Supply Chain intends to enter into arrangements under which it will be entitled to purchase supplies and/or services which it will make available for purchase by
1) any NHS Trust;
2) any other NHS entity;
3) any government department agency or other statutory body and/or
4) any private sector entity active in the UK healthcare sector. Only NHS Supply Chain can order from the Framework Agreement and enter into contracts under it.
NHS Supply Chain is currently considering the use of lots for this procurement. However it reserves the right not to as part of any future tender process. Further information in respect of the lot strategy will be set out in the notice for the forthcoming procurement.
Please first register your interest in this opportunity at: http://procurement.supplychain.nhs.uk/ISSIf you would then like to contact NHS Supply Chain about this opportunity please contact Jenny Moult through the (ISS) messaging centre who will co-ordinate a response for you.

In addition NHS Supply Chain anticipates holding a consultation meeting with suppliers during March 2013. If you would like to attend this event please contact Jenny Moult via http://procurement.supplychain.nhs.uk/ISS to register your attendance.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

N/A.
III.2)Conditions for participation
III.2.1)Information about reserved contracts

Section VI: Complementary information

VI.1)Information about European Union funds
VI.2)Additional information:
VI.3)Information on general regulatory framework

VI.4)Date of dispatch of this notice:7.2.2013